(BEN) Franklin Resources - Ratings and Ratios
Mutual Funds, Equity, Fixed Income, Balanced, Multi-Asset
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.76% |
| Yield on Cost 5y | 6.05% |
| Yield CAGR 5y | 3.37% |
| Payout Consistency | 83.4% |
| Payout Ratio | 77.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 28.5% |
| Value at Risk 5%th | 43.5% |
| Relative Tail Risk | -7.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.16 |
| Alpha | 21.69 |
| CAGR/Max DD | 0.00 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.508 |
| Beta | 1.043 |
| Beta Downside | 0.929 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.55% |
| Mean DD | 23.65% |
| Median DD | 23.42% |
Description: BEN Franklin Resources January 04, 2026
Franklin Resources, Inc. (NYSE: BEN) is a publicly traded asset-investment manager that offers equity, fixed-income, balanced, and multi-asset mutual funds through its subsidiaries to a broad client base that includes individuals, institutions, pension plans, trusts, and partnerships.
As of FY 2023, the firm reported roughly $1.5 trillion in assets under management (AUM), generated $6.5 billion in revenue, and posted net income of about $1.1 billion, delivering a return on equity near 13 %.
Key drivers for the asset-management sector include fee compression from the rise of passive products, the impact of interest-rate cycles on fixed-income performance, and demographic trends that boost demand for retirement-focused solutions; Franklin’s diversified product suite positions it to capture inflows across these dynamics.
For a deeper quantitative view, you might explore Franklin Resources’ profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (524.9m TTM) > 0 and > 6% of Revenue (6% = 526.2m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 0.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 36.82% (prev 47.99%; Δ -11.17pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 1.07b > Net Income 524.9m (YES >=105%, WARN >=100%) |
| Net Debt (9.73b) to EBITDA (1.41b) ratio: 6.88 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.71 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (515.4m) change vs 12m ago -0.15% (target <= -2.0% for YES) |
| Gross Margin 80.34% (prev 80.11%; Δ 0.24pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 27.06% (prev 26.11%; Δ 0.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.29 (EBITDA TTM 1.41b / Interest Expense TTM 94.9m) >= 6 (WARN >= 3) |
Altman Z'' 2.64
| (A) 0.10 = (Total Current Assets 5.12b - Total Current Liabilities 1.89b) / Total Assets 32.37b |
| (B) 0.36 = Retained Earnings (Balance) 11.52b / Total Assets 32.37b |
| (C) 0.03 = EBIT TTM 881.7m / Avg Total Assets 32.42b |
| (D) 0.61 = Book Value of Equity 11.12b / Total Liabilities 18.18b |
| Total Rating: 2.64 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.19
| 1. Piotroski 4.50pt |
| 2. FCF Yield 3.92% |
| 3. FCF Margin 10.39% |
| 4. Debt/Equity 1.10 |
| 5. Debt/Ebitda 6.88 |
| 6. ROIC - WACC (= -2.32)% |
| 7. RoE 4.28% |
| 8. Rev. Trend 47.78% |
| 9. EPS Trend -66.69% |
What is the price of BEN shares?
Over the past week, the price has changed by +1.40%, over one month by +9.82%, over three months by +16.37% and over the past year by +39.00%.
Is BEN a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 7
- Sell: 2
- Strong Sell: 2
What are the forecasts/targets for the BEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 25.6 | -1.4% |
| Analysts Target Price | 25.6 | -1.4% |
| ValueRay Target Price | 30.9 | 18.8% |
BEN Fundamental Data Overview January 19, 2026
P/E Forward = 10.6157
P/S = 1.5456
P/B = 1.1224
P/EG = 0.4035
Revenue TTM = 8.77b USD
EBIT TTM = 881.7m USD
EBITDA TTM = 1.41b USD
Long Term Debt = 12.30b USD (from longTermDebt, last quarter)
Short Term Debt = 1.00b USD (from shortTermDebt, last fiscal year)
Debt = 13.30b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.73b USD (from netDebt column, last quarter)
Enterprise Value = 23.28b USD (13.56b + Debt 13.30b - CCE 3.57b)
Interest Coverage Ratio = 9.29 (Ebit TTM 881.7m / Interest Expense TTM 94.9m)
EV/FCF = 25.54x (Enterprise Value 23.28b / FCF TTM 911.6m)
FCF Yield = 3.92% (FCF TTM 911.6m / Enterprise Value 23.28b)
FCF Margin = 10.39% (FCF TTM 911.6m / Revenue TTM 8.77b)
Net Margin = 5.98% (Net Income TTM 524.9m / Revenue TTM 8.77b)
Gross Margin = 80.34% ((Revenue TTM 8.77b - Cost of Revenue TTM 1.72b) / Revenue TTM)
Gross Margin QoQ = 81.81% (prev 79.25%)
Tobins Q-Ratio = 0.72 (Enterprise Value 23.28b / Total Assets 32.37b)
Interest Expense / Debt = 0.19% (Interest Expense 25.2m / Debt 13.30b)
Taxrate = 25.87% (65.8m / 254.3m)
NOPAT = 653.6m (EBIT 881.7m * (1 - 25.87%))
Current Ratio = 2.71 (Total Current Assets 5.12b / Total Current Liabilities 1.89b)
Debt / Equity = 1.10 (Debt 13.30b / totalStockholderEquity, last quarter 12.08b)
Debt / EBITDA = 6.88 (Net Debt 9.73b / EBITDA 1.41b)
Debt / FCF = 10.67 (Net Debt 9.73b / FCF TTM 911.6m)
Total Stockholder Equity = 12.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.62% (Net Income 524.9m / Total Assets 32.37b)
RoE = 4.28% (Net Income TTM 524.9m / Total Stockholder Equity 12.27b)
RoCE = 3.59% (EBIT 881.7m / Capital Employed (Equity 12.27b + L.T.Debt 12.30b))
RoIC = 2.68% (NOPAT 653.6m / Invested Capital 24.42b)
WACC = 5.00% (E(13.56b)/V(26.86b) * Re(9.76%) + D(13.30b)/V(26.86b) * Rd(0.19%) * (1-Tc(0.26)))
Discount Rate = 9.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.78%
[DCF Debug] Terminal Value 85.06% ; FCFF base≈864.6m ; Y1≈767.7m ; Y5≈640.9m
Fair Price DCF = 18.56 (EV 19.40b - Net Debt 9.73b = Equity 9.68b / Shares 521.4m; r=5.90% [WACC]; 5y FCF grow -13.79% → 2.90% )
EPS Correlation: -66.69 | EPS CAGR: -11.95% | SUE: 0.58 | # QB: 0
Revenue Correlation: 47.78 | Revenue CAGR: 1.41% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.62 | Chg30d=-0.013 | Revisions Net=+1 | Analysts=6
EPS current Year (2026-09-30): EPS=2.50 | Chg30d=-0.021 | Revisions Net=+0 | Growth EPS=+12.6% | Growth Revenue=-0.8%
EPS next Year (2027-09-30): EPS=2.81 | Chg30d=-0.003 | Revisions Net=+0 | Growth EPS=+12.4% | Growth Revenue=+3.6%
Additional Sources for BEN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle